Matinas Biopharma (MTNB) Q3 2024 Earnings

Aug 14Confirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-1.25
-0.84
-0.44
-0.03

Details

Expected EPS
-1.25
Actual EPS
-1
Surprise EPS
0.25
Surprise Percent
+20%

Description

⁨Matinas Biopharma⁩ (⁦MTNB⁩) has reported earnings of ⁦-1⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts